Emerging Gene Therapies for Inherited Arrhythmia Syndromes

Area of Science:

• Cardiovascular Medicine
• Genetics
• Molecular Biology

Background:

• Inherited arrhythmia syndromes cause sudden cardiac death, with limited treatment options and significant side effects.
• Current therapies for these conditions are often inadequate, necessitating novel approaches.
• Gene therapy presents a promising avenue by directly addressing the genetic basis of arrhythmogenesis.

Purpose of the Study:

• To review advances in nucleic acid-based gene therapies for inherited cardiac arrhythmias.
• To highlight preclinical successes and ongoing clinical trials.
• To discuss limitations and future directions in the field.

Main Methods:

• Review of preclinical and clinical data on nucleic acid-based therapies.
• Analysis of gene therapy vector transfection in cardiac tissue.
• Exploration of therapeutic potential and challenges.

Main Results:

• Significant preclinical successes in gene therapy for inherited arrhythmias, with some progressing to clinical trials.
• Identification of heterogeneous cardiac transfection as a critical factor with potential pro-arrhythmic risks and therapeutic opportunities.
• Accumulating evidence supports the potential of gene therapy for treating these conditions.

Conclusions:

• Nucleic acid-based gene therapies hold significant promise for treating inherited cardiac arrhythmias.
• Addressing challenges like transfection heterogeneity is crucial for safe and effective treatment.
• Future research should expand to more common arrhythmias like atrial fibrillation and post-MI ventricular tachycardia.